FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022205639> ?p ?o ?g. }

• W2022205639 endingPage "465" @default.
• W2022205639 startingPage "459" @default.
• W2022205639 abstract "Background: A variety of methods to improve skin flap survival, including the use of pharmacologic agents, have been intensively investigated. Decreasing neutrophil-mediated inflammation and tissue injury has been reported to be effective in improving flap survival. Montelukast is a selective reversible cysteinyl leukotriene receptor-1 antagonist that has been found to have protective effects against renal ischemia reperfusion injury and burn-induced oxidative injury of the skin in rats. However, its effects on skin flap survival have not been previously reported. Objective: The aim of this study was to investigate the effects of montelukast on neutrophil-mediated random pattern skin flap survival. Methods: Male Sprague-Dawley rats weighing 230 to 250 g were randomly divided into 2 groups—the montelukast-treated group and the control group. Caudally based rectangular random pattern skin flaps 3 × 9 cm were elevated on the backs of the rats. The flaps were sutured into their original places. In the montelukast group, 1 mL of solution containing 10 mg/kg montelukast was administered intraperitoneally (IP) 30 minutes before surgery and then daily for 6 days. In the control group, 1 mL of saline was administered IP 30 minutes before surgery and then daily for 6 days. To observe the effects of montelukast, myeloperoxidase (MPO) activity, an index of tissue neutrophil infiltration, was measured from extracted skin tissue 12 hours after flap elevation. Flap viability was evaluated 7 days after surgery by measuring necrotic flap area and total flap area. Results: Sixteen rats (mean [SD] weight, 240.6 [6.6] g) were equally divided between the 2 groups. All rats survived throughout the study period. Mean (SD) MPO activity in flap tissue was significantly lower in the montelukast group than in the control group (14.57 [2.33] vs 21.28 [4.86] U/g protein; P = 0.005). The percentage of necrotic flap area was significantly lower in the montelukast group than in the control group (17.17 [7.95] vs 37.51 [10.72]; P = 0.001). Conclusion: This small, experimental, in vivo animal study found that montelukast was associated with both lower MPO activity and a lower percentage of necrotic random pattern skin flap area. Future studies are needed to clarify these findings." @default.
• W2022205639 created "2016-06-24" @default.
• W2022205639 creator A5028295943 @default.
• W2022205639 creator A5034788749 @default.
• W2022205639 creator A5070517706 @default.
• W2022205639 creator A5077562530 @default.
• W2022205639 creator A5083112188 @default.
• W2022205639 creator A5085949923 @default.
• W2022205639 date "2008-10-01" @default.
• W2022205639 modified "2023-10-02" @default.
• W2022205639 title "The effects of montelukast on random pattern skin flap survival: An experimental study in rats" @default.
• W2022205639 cites W1530739311 @default.
• W2022205639 cites W1571779957 @default.
• W2022205639 cites W1963645152 @default.
• W2022205639 cites W1968884368 @default.
• W2022205639 cites W1969411592 @default.
• W2022205639 cites W1982581192 @default.
• W2022205639 cites W1987342201 @default.
• W2022205639 cites W1993754097 @default.
• W2022205639 cites W2013569488 @default.
• W2022205639 cites W2020033029 @default.
• W2022205639 cites W2020358486 @default.
• W2022205639 cites W2020406425 @default.
• W2022205639 cites W2020763294 @default.
• W2022205639 cites W2036661469 @default.
• W2022205639 cites W2048014052 @default.
• W2022205639 cites W2048991693 @default.
• W2022205639 cites W2062431110 @default.
• W2022205639 cites W2067236475 @default.
• W2022205639 cites W2067709564 @default.
• W2022205639 cites W2070263533 @default.
• W2022205639 cites W2077813064 @default.
• W2022205639 cites W2081145676 @default.
• W2022205639 cites W2082921904 @default.
• W2022205639 cites W2118590544 @default.
• W2022205639 cites W2160310528 @default.
• W2022205639 cites W2186052124 @default.
• W2022205639 cites W239250539 @default.
• W2022205639 doi "https://doi.org/10.1016/j.curtheres.2008.10.003" @default.
• W2022205639 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3969934" @default.
• W2022205639 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24692820" @default.
• W2022205639 hasPublicationYear "2008" @default.
• W2022205639 type Work @default.
• W2022205639 sameAs 2022205639 @default.
• W2022205639 citedByCount "5" @default.
• W2022205639 countsByYear W20222056392020 @default.
• W2022205639 countsByYear W20222056392021 @default.
• W2022205639 crossrefType "journal-article" @default.
• W2022205639 hasAuthorship W2022205639A5028295943 @default.
• W2022205639 hasAuthorship W2022205639A5034788749 @default.
• W2022205639 hasAuthorship W2022205639A5070517706 @default.
• W2022205639 hasAuthorship W2022205639A5077562530 @default.
• W2022205639 hasAuthorship W2022205639A5083112188 @default.
• W2022205639 hasAuthorship W2022205639A5085949923 @default.
• W2022205639 hasBestOaLocation W20222056391 @default.
• W2022205639 hasConcept C121332964 @default.
• W2022205639 hasConcept C126322002 @default.
• W2022205639 hasConcept C141071460 @default.
• W2022205639 hasConcept C153400128 @default.
• W2022205639 hasConcept C170493617 @default.
• W2022205639 hasConcept C203565725 @default.
• W2022205639 hasConcept C2776042228 @default.
• W2022205639 hasConcept C2776322731 @default.
• W2022205639 hasConcept C2776885963 @default.
• W2022205639 hasConcept C2776914184 @default.
• W2022205639 hasConcept C2777397205 @default.
• W2022205639 hasConcept C2780212800 @default.
• W2022205639 hasConcept C2991913917 @default.
• W2022205639 hasConcept C42219234 @default.
• W2022205639 hasConcept C541997718 @default.
• W2022205639 hasConcept C71924100 @default.
• W2022205639 hasConcept C97355855 @default.
• W2022205639 hasConceptScore W2022205639C121332964 @default.
• W2022205639 hasConceptScore W2022205639C126322002 @default.
• W2022205639 hasConceptScore W2022205639C141071460 @default.
• W2022205639 hasConceptScore W2022205639C153400128 @default.
• W2022205639 hasConceptScore W2022205639C170493617 @default.
• W2022205639 hasConceptScore W2022205639C203565725 @default.
• W2022205639 hasConceptScore W2022205639C2776042228 @default.
• W2022205639 hasConceptScore W2022205639C2776322731 @default.
• W2022205639 hasConceptScore W2022205639C2776885963 @default.
• W2022205639 hasConceptScore W2022205639C2776914184 @default.
• W2022205639 hasConceptScore W2022205639C2777397205 @default.
• W2022205639 hasConceptScore W2022205639C2780212800 @default.
• W2022205639 hasConceptScore W2022205639C2991913917 @default.
• W2022205639 hasConceptScore W2022205639C42219234 @default.
• W2022205639 hasConceptScore W2022205639C541997718 @default.
• W2022205639 hasConceptScore W2022205639C71924100 @default.
• W2022205639 hasConceptScore W2022205639C97355855 @default.
• W2022205639 hasIssue "5" @default.
• W2022205639 hasLocation W20222056391 @default.
• W2022205639 hasLocation W20222056392 @default.
• W2022205639 hasLocation W20222056393 @default.
• W2022205639 hasLocation W20222056394 @default.
• W2022205639 hasOpenAccess W2022205639 @default.
• W2022205639 hasPrimaryLocation W20222056391 @default.
• W2022205639 hasRelatedWork W2022205639 @default.
• W2022205639 hasRelatedWork W2072084977 @default.

• next